Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Phase 1

Completed

Conditions: Chromophobe Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Papillary Renal Cell Carcinoma
Recurrent Renal Cell Carcinoma
Sarcomatoid Renal Cell Carcinoma
Stage IV Renal Cell Cancer

Interventions: Biological: Bevacizumab
Drug: Sorafenib Tosylate
Other: Pharmacological Study
Other: Laboratory Biomarker Analysis

First Posted Date: 2005-08-04

Last Posted Date: 2015-01-15

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 73

Registration Number: NCT00126503

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Harvard Cancer Center, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 2 locations

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Phase 2

Completed

Conditions: Stage IV Renal Cell Cancer
Recurrent Renal Cell Carcinoma

Interventions: Biological: Aldesleukin
Biological: Bevacizumab
Other: Laboratory Biomarker Analysis

First Posted Date: 2005-08-04

Last Posted Date: 2015-06-30

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 19

Registration Number: NCT00126490

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer

Phase 2

Terminated

Conditions: Recurrent Renal Cell Cancer
Stage IV Renal Cell Cancer
Clear Cell Renal Cell Carcinoma

Interventions: Procedure: therapeutic conventional surgery
Drug: sorafenib tosylate
Other: laboratory biomarker analysis

First Posted Date: 2005-08-04

Last Posted Date: 2018-11-20

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 10

Registration Number: NCT00126659

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

SAMe to Treat Biliary Cirrhosis Symptoms

Phase 2

Terminated

Conditions: Liver Cirrhosis, Biliary

First Posted Date: 2005-07-29

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 50

Registration Number: NCT00125281

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Internet Weight Control for Bingeing Adolescents

Phase 1

Completed

Conditions: Obesity
Eating Disorders

First Posted Date: 2005-07-29

Last Posted Date: 2010-01-18

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 120

Registration Number: NCT00125112

Locations: 🇺🇸
Stanford University Department of Psychiatry and Behavioral Sciences, Stanford, California, United States

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

Phase 1

Completed

Conditions: Refractory Multiple Myeloma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: pamidronate disodium
Drug: arsenic trioxide
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2005-07-28

Last Posted Date: 2013-01-07

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 24

Registration Number: NCT00124605

Locations: 🇺🇸
City of Hope, Duarte, California, United States

Biofeedback for Fecal Incontinence

Not Applicable

Completed

Conditions: Fecal Incontinence

First Posted Date: 2005-07-28

Last Posted Date: 2010-01-13

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 165

Registration Number: NCT00124904

Locations: 🇺🇸
University of North Carolina Department of Medicine, Chapel Hill, North Carolina, United States

Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

Phase 1

Terminated

Conditions: Prostate Cancer

Interventions: Radiation: Radiation

First Posted Date: 2005-07-28

Last Posted Date: 2019-09-13

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 6

Registration Number: NCT00124917

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)

Phase 3

Completed

Conditions: Bladder Diseases
Interstitial Cystitis

Interventions: Other: Placebo
Drug: Amitriptyline

First Posted Date: 2005-07-27

Last Posted Date: 2013-10-30

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 271

Registration Number: NCT00124306

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States
🇨🇦
Queen's University, Kingston, Ontario, Canada
🇺🇸
Stanford University Medical Center, Stanford, California, United States

and more 7 locations

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Phase 2

Completed

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size
Extraocular Extension Melanoma
Iris Melanoma
Uveal Melanoma
Recurrent Intraocular Melanoma
Recurrent Melanoma
Stage IV Melanoma

Interventions: Drug: vorinostat

First Posted Date: 2005-07-21

Last Posted Date: 2019-01-29

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 32

Registration Number: NCT00121225

Locations: 🇺🇸
Fox Chase Cancer Center, Rockledge, Pennsylvania, United States
🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦
Princess Margaret Hospital Phase 2 Consortium, Toronto, Ontario, Canada

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy